AARD Financials
Aardvark Therapeutics Inc - Financial statements & key metrics
Stock Price
$5.37
Market Cap
$120.64M
EPS
$-2.93
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$0.00
Gross Profit
$-36000.00
Operating Income
$-62.73M
Net Income
$-57.59M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$117.18M
Total Liabilities
$10.55M
Shareholders Equity
$106.63M
Cash & Equivalents
$47.05M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-54.17M
CapEx
$95000
Free Cash Flow
$-54.27M
Profitability Metrics
ROE
-0.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AARD revenue?
AARD's most recent quarterly revenue was $0.00. Annual revenue can be calculated by summing the four most recent quarters.
Is AARD profitable?
AARD reported a loss of $57.59M in the most recent quarter.
What is AARD market cap?
AARD has a market capitalization of $120.64M, making it a small-cap stock.
Does AARD have debt?
View AARD's balance sheet for debt information.
What is AARD cash flow?
AARD's most recent quarterly free cash flow was $-54.27M.